Kenneth Truitt - 06 Sep 2022 Form 4 Insider Report for Aquestive Therapeutics, Inc. (AQST)

Role
Chief Medical Officer
Signature
/s/ Lori Braender, as Attorney-In-Fact
Issuer symbol
AQST
Transactions as of
06 Sep 2022
Net transactions value
$0
Form type
4
Filing time
08 Sep 2022, 16:30:27 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AQST Non-Qualified Stock Option (right to buy) Award $0 +100,000 $0.000000 100,000 06 Sep 2022 Common Stock 100,000 $1.25 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Granted as an inducement equity award under the Aquestive Therapeutics, Inc. 2022 Inducement Equity Incentive Plan in accordance with Nasdaq Listing Rule 5636(c)(4). The options will vest annually 25% on the first and second anniversaries of the Grant Date and 50% on the third anniversary of the Grant Date, subject to Dr. Truitt's continued employment through the applicable vesting date.